JPMorgan analyst Priyanka Grover downgraded Mereo BipPharma Group (NASDAQ: MREO) from Neutral to Underweight.

For an analyst ratings summary and ratings history on Mereo BipPharma Group click here. For more ratings news on Mereo BipPharma Group click here.

Shares of Mereo BipPharma Group closed at $0.31 yesterday.